Herbal hope for hot flashes: ashwagandha trial launches
NCT ID NCT07210229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special ashwagandha extract can reduce menopause symptoms like hot flashes and improve quality of life. About 90 women with moderate-to-severe symptoms will take either the herb or a placebo for several weeks. Researchers will measure symptom scores and hormone levels to see if the supplement works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness and demonstrated ability to comply with all study procedures, as well as availability for the duration of the study * Baseline score of above-average menopause symptom levels on each of the patient reported scales: NRI-MSS (defined as 22+), the MRS scale (defined as 9+), AND 4+ on the MENQoL. * Confirmation of presence of hot flashes * Estridiol levels within the bottom 35% of normal ranges for their menstrual cycle phase (follicular/ovulation/luteal) as established by laboratory reference range * Biological sex of female; gender identification of woman * Aged 40 to 55, inclusive * Good general health as evidenced by medical history and screening * For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of the study * Still menstruating regularly (defined at least one period every 60 days) * Agreement to adhere to Lifestyle Considerations throughout study duration Exclusion Criteria: * Pregnant, trying to conceive, or breastfeeding * Hysterectomy, uterine ablation, or related procedure * Amenorrhea * Consumes \> 8 alcoholic beverages in an average week * Currently consumes an ashwagandha supplement or has consumed one regularly (defined as 1x week or more often) within the past 24 months * Consumes any hormonal therapies or menopause-related supplements intended to improve symptoms in any way * Current or recent (within 60 days) history of taking thyroid medications, hypertensive drugs, CNS depressants, diabetic medications, benzodiazepines, or immunosuppressants * Any liver, kidney, hormonal, or cardiovascular disorder * Known allergic reactions to any components of the intervention * Recent dramatic weight changes (10% change in body weight in the last 6 months) * Introducing a new investigational drug or other intervention within 60 days before the start of the study * Any change to diet or lifestyle within 60 days before the start of the study (defined as introducing any new exercise activity, joining a gym, starting a new routine, moving to a new home, adjusting dietary habits (e.g. vegetarian, paleo, etc) or discontinuing any habits or diets. * Any health or medical condition which, in the primary investigators opinion, may interfere with the conduct of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Menopausal hot flashes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Nutraceuticals Research Institute
Huntsville, Alabama, 35801, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tests talking therapy for menopause symptoms
- Which progesterone works best for menopause? new study aims to find out
- Menopause relief without pills: education program shows promise for hot flashes
- New study aims to fix heart risk calculators that fail women
- Menopausal Women's skin changes under microscope in new study
- Which sleep therapy works best for menopausal women? major study aims to find out